Koers Can-Fite BioPharma Ltd. TEL AVIV STOCK EXCHANGE
Aandelen
CANF
IL0010944739
Farmaceutische producten
Omzet 2024 * | 800K 3,04 mln. 748K | Omzet 2025 * | 800K 3,04 mln. 748K | Marktkapitalisatie | 10,29 mln. 39,08 mln. 9,63 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -6 mln. -22,77 mln. -5,61 mln. | Nettowinst (verlies) 2025 * | -7 mln. -26,57 mln. -6,55 mln. | EV/omzet 2024 * | 12,9 x |
Nettoliquiditeiten 2024 * | - 0 0 | Nettoliquiditeiten 2025 * | - 0 0 | EV/omzet 2025 * | 12,9 x |
K/w-verhouding 2024 * |
-
| K/w-verhouding 2025 * |
-
| Werknemers | - |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 99,97% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Motti Farbstein
CEO | Chief Executive Officer | 59 | 01-08-03 |
Pnina Fishman
FOU | Founder | 74 | 11-09-94 |
Ilan Cohn
FOU | Founder | 67 | 11-09-94 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Abraham Sartani
BRD | Director/Board Member | 76 | 01-01-01 |
Ilan Cohn
FOU | Founder | 67 | 11-09-94 |
Pnina Fishman
FOU | Founder | 74 | 11-09-94 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
-2,86% | 87,31 mld. | |
+3,95% | 40,86 mld. | |
-21,94% | 29,36 mld. | |
+56,40% | 24,49 mld. | |
-5,41% | 17,31 mld. | |
-17,60% | 11,62 mld. | |
-13,96% | 11,31 mld. | |
-44,23% | 11,26 mld. | |
+7,27% | 8,31 mld. |